Advertisement

Topics

Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer

20:00 EDT 13 Jun 2018 | Breast Cancer Research

Obesity and type II diabetes are linked to increased breast cancer risk in postmenopausal women. Patients treated with the antidiabetic drug metformin for diabetes or metabolic syndrome have reduced breast can...

Original Article: Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer

NEXT ARTICLE

More From BioPortfolio on "Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...